CITIUS PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.6675 USD | +6.85% |
|
-4.79% | -11.76% |
| 05-14 | Citius Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024 | CI |
| 04-26 | Citius Pharmaceuticals Launches $15 Million Offering | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CITIUS PHARMACEUTICALS, INC. | Other Biotechnology & Medical Research | +6.85% | -4.79% | -11.76% | -46.60% | -47.44% | 121M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- CTXR Stock
- Charts Citius Pharmaceuticals, Inc.
- Comparison Chart
